This evolution allowed nuclear medicine to constantly challenge other imaging and therapeutic modalities, as shown recently by Hirmas et al. [2] where they demonstrated the superiority of Ga-68-labelled PSMA over conventionally used Computed Tomography (CT) in the diagnosis and treatment management of hepatocellular carcinoma (HCC) patients. Here, FOLH1 is linked to hepatocellular carcinoma.